GLP-1 drugs like semaglutide and tirzepatide have rewritten the rules of weight loss and diabetes care, but the story turns ...

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

With GLP-1 use rising across the country, major brands are boosting protein, cutting sugar, and reworking formulations and ...

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

Researchers from Japan discover that glucagon-like peptide-2 (GLP-2) analogs can deeply and beneficially reshape the intestinal environment. Short bowel syndrome (SBS) represents one of the most ...

GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...

SYDNEY, AUSTRALIA - JANUARY 13: Ozempic is medicine for adults with type 2 diabetes . Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient ...

A study found patients with type 2 diabetes treated with GLP-1 receptor agonists were less likely to develop peptic ulcer disease (PUD). As a second-line therapy, GLP-1 drugs also appeared to be more ...

Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a "weight-inclusive" healthcare company based in Boston, said she would caution against labeling any medication as an "everything ...